CSPC Pharmaceutical Group Limited. Overview

CSPC Pharmaceutical Group Limited. Research & Development

Research & Development expenses for CSPCY.

Quarterly R&D Expenses

$3.42B

↑ 14.51% YoY

As of Dec 31, 2025

Annual R&D Expenses (TTM)

$10.71B

↑ 114.54% YoY

Trailing 12 months ending Dec 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin